Introduction: Reports of hypertrophic spinal pachymeningitis associated with human T-cell lymphotrophic virus-1 (HTLV-1) infection and Sjogren's syndrome in the English literature are still very rare.

Presentation Of Case: We hereby present a case of a 78-year-old female with a history of lower extremity weakness after a fall, which fully resolved after conservative treatment. However, the symptoms recurred 4 years later, and the patient became unable to walk. The patient had no superficial or deep sensation below the level of T9, and she also had urinary retention. Magnetic resonance imaging showed that hypertrophic dura mater was compressing the spinal cord from T2 to T10. Blood testing revealed increased anti-HTLV-1 antibody, rheumatoid factor, elevation of anti-SS-A antibody and antinuclear antibody. The cerebrospinal fluid contained markedly elevated levels of total protein and cell numbers. Biopsy of the labial gland of the lip revealed chronic sialadenitis.

Discussion: In collaboration with a neurologist, we diagnosed this patient with hypertrophic spinal pachymeningitis associated with HTLV-1 infection and Sjogren's syndrome. We performed laminectomy at the affected spinal levels, resected the thickened dura, and maintained the patient on steroid therapy. The patient attained a marked recovery; she could walk with a cane and her urinary retention was improved.

Conclusion: For the management of HSP associated with HTLV-1 and SS, we recommend surgical decompression with subsequent prolonged steroid therapy and prolonged close monitoring to achieve a good long-term outcome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000741PMC
http://dx.doi.org/10.1016/j.ijscr.2018.03.010DOI Listing

Publication Analysis

Top Keywords

hypertrophic spinal
12
spinal pachymeningitis
12
pachymeningitis associated
12
infection sjogren's
12
sjogren's syndrome
12
associated human
8
human t-cell
8
t-cell lymphotrophic
8
lymphotrophic virus-1
8
htlv-1 infection
8

Similar Publications

Plasma miRNAs Correlate with Structural Brain and Cardiac Damage in Friedreich's Ataxia.

Cerebellum

December 2024

Department of Neurology, School of Medical Sciences, University of Campinas - UNICAMP, Rua Tessália Vieira de Camargo, 126. Cidade Universitária "Zeferino Vaz" Campinas, Campinas, SP, 13083-887, Brazil.

Friedreich's Ataxia (FRDA) is the most common autosomal recessive ataxia worldwide and is caused by biallelic unstable intronic GAA expansions at FXN. With its limited therapy and the recent approval of the first disease-modifying agent for FRDA, the search for biological markers is urgently needed to assist and ease the development of therapies. MiRNAs have emerged as promising biomarkers in various medical fields such as oncology, cardiology, epilepsy and neurology as well.

View Article and Find Full Text PDF

Introduction: Ligamentum flavum (LF) hypertrophy is the main etiological factor in the development of lumbar spinal stenosis (LSS); however, its molecular pathology remains unclear. Histologically, LF hypertrophy is characterized by a reduction in elastic fibers and an increase in collagen fibers. We previously performed miRNA transcriptomic analysis on excised LF from elderly patients with LSS and identified the insulin receptor signaling along with TGFβ-mediated signaling as pathways involved in ligament hypertrophy.

View Article and Find Full Text PDF

Background Context: The ligamentum flavum (LF) is a crucial structure in maintaining spinal stability; however, hypertrophy of the LF is a significant contributor to lumbar spinal canal stenosis (LSCS).The mechanisms linking LF hypertrophy to the exacerbation of LSCS remain incompletely understood.

Purpose: This study aimed to investigate the cellular proportions and signaling pathways observed in the hypertrophied LF.

View Article and Find Full Text PDF

Ligamentum flavum degeneration, including hypertrophy and ossification of the ligamentum flavum, leads to degenerative spinal stenosis in older adults. However, the underlying mechanisms of ligamentum flavum degeneration remain unclear, and therapeutic strategies are limited. Noncoding RNAs include microRNAs, circular RNAs, and long noncoding RNAs.

View Article and Find Full Text PDF

Objective: This research aims to assess the clinical and radiological outcomes of both dynamic rod system (PLSDR) and rigid rod system (PLSRR) when treating lumbar degenerative disease (LDD).

Method: A retrospective review of 98 patients who underwent posterior stabilization surgery with a posterior approach in our clinic between 2018 and 2023 was conducted. The patients were divided into two groups based on the type of implant used: Those with PLSRR (Group 1) and those with PLSDR (Group 2).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!